Non-diabetic patients who received 15mg weekly for 72 weeks (about 17 months) lost an average of 22.5% of their body weight, compared to 2.4% of the placebo group
Obesity is not just a risk factor for other diseases, such as cardiovascular diseases, type 2 diabetes (T2DM), arthritis, and some cancers (6), but also a complex disease with multiple causes, which has its own disabling ability, pathophysiology, and co-morbidities (7)
These procedures freeze and eliminate fat cells in targeted areas but do not address skin excess
The approach we've outlined across our recovery-first training philosophy and the entire Retatrutide troubleshooting series is built around this reality: slower, smarter results that stick
Open 6 , e2314493 (2023)
US National Library of Medicine